FERROUS SULFATE REDUCES LEVODOPA BIOAVAILABILITY - CHELATION AS A POSSIBLE MECHANISM

被引：34

作者：

CAMPBELL, NRC

HASINOFF, B

机构：

[1] MEM UNIV NEWFOUNDLAND,DEPT CHEM,ST JOHNS A1C 5S7,NEWFOUNDLAND,CANADA

[2] MEM UNIV NEWFOUNDLAND,DISCIPLINE MED,ST JOHNS A1C 5S7,NEWFOUNDLAND,CANADA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 03期

关键词：

D O I：

10.1038/clpt.1989.21

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：220 / 225

页数：6

共 15 条

[1] ABD E, 1984, ANAL LETT, V17, P205
[2] COORDINATION CHEMISTRY OF MICROBIAL IRON TRANSPORT COMPOUNDS .9. STABILITY-CONSTANTS FOR CATECHOL MODELS OF ENTEROBACTIN
AVDEEF, A
SOFEN, SR
BREGANTE, TL
RAYMOND, KN
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1978, 100 (17) : 5362 - 5370
[3] ALTERATION OF METHYLDOPA ABSORPTION, METABOLISM, AND BLOOD-PRESSURE CONTROL CAUSED BY FERROUS SULFATE AND FERROUS GLUCONATE
CAMPBELL, N
PADDOCK, V
SUNDARAM, R
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (04) : 381 - 386
[4] SYSTEMIC AVAILABILITY OF ORALLY-ADMINISTERED L-DOPA IN THE ELDERLY PARKINSONIAN PATIENT
EVANS, MA
TRIGGS, EJ
BROE, GA
SAINES, N
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (03) : 215 - 221
[5] GERGELY A, 1979, MET IONS BIOL SYST, V9, P143
[6] GOLDSTEIN DS, 1984, CLIN CHEM, V30, P815
[7] THE PHARMACOKINETICS OF INTRAVENOUS AND ORAL LEVODOPA IN PATIENTS WITH PARKINSONS-DISEASE WHO EXHIBIT ON-OFF FLUCTUATIONS
HARDIE, RJ
MALCOLM, SL
LEES, AJ
STERN, GM
ALLEN, JG
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (04) : 429 - 436
[8] HILLMAN RS, 1985, GOODMAN GILMANS PHAR, P1308
[9] DIET AND UPTAKE OF ALDOMET BY BRAIN - COMPETITION WITH NATURAL LARGE NEUTRAL AMINO-ACIDS
MARKOVITZ, DC
FERNSTROM, JD
[J]. SCIENCE, 1977, 197 (4307) : 1014 - 1015
[10] INTERACTIONS OF FE(III) WITH ADRENALINE, L-DOPA AND OTHER CATECHOL DERIVATIVES - EQUILIBRIA AND KINETICS OF COMPLEX-FORMATION IN ACIDIC PERCHLORATE MEDIA
MENTASTI, E
PELIZZETTI, E
SAINI, G
[J]. JOURNAL OF INORGANIC & NUCLEAR CHEMISTRY, 1976, 38 (04): : 785 - 788

← 1 2 →